Global Alzheimer’s Therapeutic Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Alzheimer’s Therapeutic Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by Product
  • 1.4.2 Memantine Hydrochloride
  • 1.4.3 Donepezil Hydrochloride
  • 1.4.4 Rivastigmine
  • 1.4.5 Galantamine Hydrobromide
• 1.5 Market by End User
  • 1.5.1 Global Alzheimer’s Therapeutic Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Clinic
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Alzheimer’s Therapeutic Market Size
  • 2.1.1 Global Alzheimer’s Therapeutic Revenue 2014-2025
  • 2.1.2 Global Alzheimer’s Therapeutic Sales 2014-2025
• 2.2 Alzheimer’s Therapeutic Growth Rate by Regions
  • 2.2.1 Global Alzheimer’s Therapeutic Sales by Regions
  • 2.2.2 Global Alzheimer’s Therapeutic Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Alzheimer’s Therapeutic Sales by Manufacturers
  • 3.1.1 Alzheimer’s Therapeutic Sales by Manufacturers
  • 3.1.2 Alzheimer’s Therapeutic Sales Market Share by Manufacturers
  • 3.1.3 Global Alzheimer’s Therapeutic Market Concentration Ratio (CR5 and HHI)
• 3.2 Alzheimer’s Therapeutic Revenue by Manufacturers
  • 3.2.1 Alzheimer’s Therapeutic Revenue by Manufacturers (2014-2019)
  • 3.2.2 Alzheimer’s Therapeutic Revenue Share by Manufacturers (2014-2019)
• 3.3 Alzheimer’s Therapeutic Price by Manufacturers
• 3.4 Alzheimer’s Therapeutic Manufacturing Base Distribution, Product Types
  • 3.4.1 Alzheimer’s Therapeutic Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Alzheimer’s Therapeutic Product Type
  • 3.4.3 Date of International Manufacturers Enter into Alzheimer’s Therapeutic Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Alzheimer’s Therapeutic Sales by Product
• 4.2 Global Alzheimer’s Therapeutic Revenue by Product
• 4.3 Alzheimer’s Therapeutic Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Alzheimer’s Therapeutic Breakdown Data by End User

6 North America

• 6.1 North America Alzheimer’s Therapeutic by Countries
  • 6.1.1 North America Alzheimer’s Therapeutic Sales by Countries
  • 6.1.2 North America Alzheimer’s Therapeutic Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Alzheimer’s Therapeutic by Product
• 6.3 North America Alzheimer’s Therapeutic by End User

7 Europe

• 7.1 Europe Alzheimer’s Therapeutic by Countries
  • 7.1.1 Europe Alzheimer’s Therapeutic Sales by Countries
  • 7.1.2 Europe Alzheimer’s Therapeutic Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Alzheimer’s Therapeutic by Product
• 7.3 Europe Alzheimer’s Therapeutic by End User

8 Asia Pacific

• 8.1 Asia Pacific Alzheimer’s Therapeutic by Countries
  • 8.1.1 Asia Pacific Alzheimer’s Therapeutic Sales by Countries
  • 8.1.2 Asia Pacific Alzheimer’s Therapeutic Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Alzheimer’s Therapeutic by Product
• 8.3 Asia Pacific Alzheimer’s Therapeutic by End User

9 Central & South America

• 9.1 Central & South America Alzheimer’s Therapeutic by Countries
  • 9.1.1 Central & South America Alzheimer’s Therapeutic Sales by Countries
  • 9.1.2 Central & South America Alzheimer’s Therapeutic Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Alzheimer’s Therapeutic by Product
• 9.3 Central & South America Alzheimer’s Therapeutic by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Alzheimer’s Therapeutic by Countries
  • 10.1.1 Middle East and Africa Alzheimer’s Therapeutic Sales by Countries
  • 10.1.2 Middle East and Africa Alzheimer’s Therapeutic Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Alzheimer’s Therapeutic by Product
• 10.3 Middle East and Africa Alzheimer’s Therapeutic by End User

11 Company Profiles

• 11.1 Pfizer Inc
  • 11.1.1 Pfizer Inc Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Pfizer Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Pfizer Inc Alzheimer’s Therapeutic Products Offered
  • 11.1.5 Pfizer Inc Recent Development
• 11.2 Novartis International AG
  • 11.2.1 Novartis International AG Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Novartis International AG Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Novartis International AG Alzheimer’s Therapeutic Products Offered
  • 11.2.5 Novartis International AG Recent Development
• 11.3 Axovant Sciences Ltd
  • 11.3.1 Axovant Sciences Ltd Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Axovant Sciences Ltd Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Axovant Sciences Ltd Alzheimer’s Therapeutic Products Offered
  • 11.3.5 Axovant Sciences Ltd Recent Development
• 11.4 Acadia Pharmaceuticals, Inc
  • 11.4.1 Acadia Pharmaceuticals, Inc Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Acadia Pharmaceuticals, Inc Alzheimer’s Therapeutic Products Offered
  • 11.4.5 Acadia Pharmaceuticals, Inc Recent Development
• 11.5 Biotie Therapies
  • 11.5.1 Biotie Therapies Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Biotie Therapies Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Biotie Therapies Alzheimer’s Therapeutic Products Offered
  • 11.5.5 Biotie Therapies Recent Development
• 11.6 Astra Zeneca plc
  • 11.6.1 Astra Zeneca plc Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Astra Zeneca plc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Astra Zeneca plc Alzheimer’s Therapeutic Products Offered
  • 11.6.5 Astra Zeneca plc Recent Development
• 11.7 Eli Lilly, Inc
  • 11.7.1 Eli Lilly, Inc Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Eli Lilly, Inc Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Eli Lilly, Inc Alzheimer’s Therapeutic Products Offered
  • 11.7.5 Eli Lilly, Inc Recent Development
• 11.8 F. Hoffman Le Roche
  • 11.8.1 F. Hoffman Le Roche Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 F. Hoffman Le Roche Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 F. Hoffman Le Roche Alzheimer’s Therapeutic Products Offered
  • 11.8.5 F. Hoffman Le Roche Recent Development
• 11.9 Merck & Co
  • 11.9.1 Merck & Co Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Merck & Co Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Merck & Co Alzheimer’s Therapeutic Products Offered
  • 11.9.5 Merck & Co Recent Development
• 11.10 H. Lundbeck A/S
  • 11.10.1 H. Lundbeck A/S Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 H. Lundbeck A/S Alzheimer’s Therapeutic Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 H. Lundbeck A/S Alzheimer’s Therapeutic Products Offered
  • 11.10.5 H. Lundbeck A/S Recent Development
• 11.11 Takeda Pharmaceutical Company Ltd

12 Future Forecast

• 12.1 Alzheimer’s Therapeutic Market Forecast by Regions
  • 12.1.1 Global Alzheimer’s Therapeutic Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Alzheimer’s Therapeutic Revenue Forecast by Regions 2019-2025
• 12.2 Alzheimer’s Therapeutic Market Forecast by Product
  • 12.2.1 Global Alzheimer’s Therapeutic Sales Forecast by Product 2019-2025
  • 12.2.2 Global Alzheimer’s Therapeutic Revenue Forecast by Product 2019-2025
• 12.3 Alzheimer’s Therapeutic Market Forecast by End User
• 12.4 North America Alzheimer’s Therapeutic Forecast
• 12.5 Europe Alzheimer’s Therapeutic Forecast
• 12.6 Asia Pacific Alzheimer’s Therapeutic Forecast
• 12.7 Central & South America Alzheimer’s Therapeutic Forecast
• 12.8 Middle East and Africa Alzheimer’s Therapeutic Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Alzheimer’s Therapeutic Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details